Up And Down The Ladder… Job Changes
Make a commentBy Ed Silverman // October 3rd, 2007 // 7:38 am
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. Here are some of the latest moves…
Wolters Kluwer Health names Cathy Betz as vp, government affairs;
Amira Pharmaceuticals named Hari Kumar chief business officer;
Pfizer hired Tanya Clemons as vp and chief talent officer;
Mylan appointed Greg Sheldon as global chief information officer;
Mylan also named Dave Lillback as sr vp and global head of HR;
Mylan taps Brian Byala as sr vp and treasurer;
Glaxo names Roy Anderson a non-executive director and board member;
Kendle named Ken Hintze vp, global clinical safety and pharmacovigilance;
Genencor hired Glenn Nedwin as exec vp, technical enzymes;
Paramount BioSciences named Robert Jacks vp of biz development;
VaxGen says independent director Jack Anthony resigned from the board;
Ondine Biopharma appointed Tim Rose chairman of its clinical advisory board;
Northwest Biotherapeutics named Anthony Deasey cfo, sr vp of finance and to its board;
Athersys elected Lorin Jeffry Randall to its board and appointed Randall chairman of the audit committee.
University of Kansas Cancer Center hired Sitta Sittampalam as deputy director of its Office of Therapeutics, Discovery and Development.
Hat tip to Pharmaceutical Executive